|
Volumn 23, Issue 4, 2001, Pages 148-152
|
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease
|
Author keywords
Antiparkinsonian drugs; Elderly; Parkinson's disease; Pharmacoepidemiology; Pharmacy records
|
Indexed keywords
AMANTADINE;
ANTIPARKINSON AGENT;
BIOCHEMICAL MARKER;
BROMOCRIPTINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
LEVODOPA;
SELEGILINE;
ADULT;
AGED;
AGING;
AREA UNDER THE CURVE;
ARTICLE;
COHORT ANALYSIS;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
PARKINSON DISEASE;
PHARMACOEPIDEMIOLOGY;
PHARMACY;
QUALITY OF LIFE;
RELIABILITY;
AGED;
AGED, 80 AND OVER;
ANTIPARKINSON AGENTS;
COHORT STUDIES;
COMMUNITY PHARMACY SERVICES;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NETHERLANDS;
PARKINSON DISEASE;
PREVALENCE;
PROSPECTIVE STUDIES;
|
EID: 0034842876
PISSN: 09281231
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1011807919632 Document Type: Article |
Times cited : (30)
|
References (21)
|